GENMAB A/S (GMXAY) analyst actions
Rating and price-target actions on GMXAY in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the GMXAY overview →
1 measured GMXAY analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Genmab Announces Initiation of Share Buy-Back Program | Press release | +1.01% | -0.47% |
Keep exploring
More GMXAY: earnings → · SEC filings → · GMXAY overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Synergy CHC Corp. (SNYR) | 126 | -0.06% | 43% |
| Accelerate Diagnostics, Inc. (AXDX) | 125 | -0.16% | 36% |
| BIOTRICITY INC (BTCY) | 124 | 0.00% | 38% |
| CLEMENTIA PHARMACEUTICALS INC COMMON SHARES (CMTA) | 124 | +0.03% | 51% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.